Details for 2015784907

Up to date per 03.04.2026

Actions

Title / Product Name

ANTIKÖRPERMOLEKÜLE GEGEN PD-L1 UND VERWENDUNGEN DAVON

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2015784907

EP Publication Number

3206711

E-Number

1570564

Language

PCT Number

US15055390

Publication Date

23.08.2017 A

31.05.2023 B1

Registration Date

31.05.2023

AT Publication Date

15.06.2023

Application Date

13.10.2015

Registration Number

Priorities

14.10.2014

201462063852 P

19.12.2014

201462094847 P

29.07.2015

201562198545 P

01.09.2015

201562213076 P

IPC

A61K 39/395 20060101AFI20221115BHEP

Maximum Duration of Protection

13.10.2035

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Dana-Farber Cancer Institute, Inc.450 Brookline Avenue Boston, MA 02215-5450US

President and Fellows of Harvard College17 Quincy Street Cambridge, MA 02138US

Representative

No representatives present

Inventor

FREEMAN, Gordon, James305 Walnut Street Brookline, MA 02445US

SHARPE, Arlene, Helen305 Walnut Street Brookline, MA 02445US

FREY, Gerhard, Johann13768 Via Cima Bella San Diego, CA 92129US

CHANG, Hwai, Wen1318 Shadow Hills Drive San Marcos, CA 92069US

MATARAZA, Jennifer, Mariec/o Novartis Institutes For Biomedical Research Inc. 250 Massachusetts Ave. Cambridgem, MA 02139US

DRANOFF, Glennc/o Novartis Institutes For Biomedical Research Inc. 250 Massachusetts Ave. Cambridge, MA 02139US